Â鶹´«Ã½

Skip to main content

Alzheimer's vaccine: Nasal spray trial shows promise, researchers say

Share

Researchers at Brigham and Women’s Hospital in Boston are testing an Alzheimer's vaccine on people.

The nasally administered vaccine, , is being tested on a group of 16 people with early Alzheimer's disease, between the ages of 60 to 85 years.

Alzheimer's is a cognitive disease that impairs a memory, thought, and language. . In 2020, with dementia.

"This (vaccine) is using some proteins to stimulate the body's own immune cells to clear away the beta-amyloid, which is really the problematic protein in Alzheimer's disease," Dr. Tanuja Chitnis, a neurologist with Brigham and Women’s Hospital, told CTV's Your Morning on Friday.

and can affect the heart, kidneys, liver, and nervous system.

The vaccine is showing positive results, but more testing is needed to understand dosages and any implications.

"We found that this drug is safe and well-tolerated," Chitnis said. "We're currently working on immunological studies to prove that the vaccine works in the way that we think it does."

If successful, this vaccine could drastically change the lives of people living with Alzheimer's, Chitnis said, allowing anyone to easily administer the drug. have experienced caring for someone living with dementia.

"Our results suggested quite safe and patients with early Alzheimer's disease, and we're hoping that it will prevent patients from progressing into those later and more problematic stages of disease in which they can't take care of themselves," Chitnis said.

Another Alzheimer's vaccine has concluded trial results from the U.K., where a randomized placebo-controlled study showed there was a 27 per cent less decline in memory after 18 months.

Chitnis believes more research on Alzheimer's vaccines is "very exciting."

"We're seeing a lot of new treatments for Alzheimer's disease," she said. "Our approach is somewhat different, again, using the body's own immune cells to actually activate and clear away amyloid." 

When asked about the trial, Joshua Armstrong, a research scientist with the Alzheimer Society of Canada, said the group would be watching for results.

"This vaccine-like approach of using a nasal spray to activate the body's immune system is a novel and innovative way of potentially addressing the beta amyloid plaques that build up in the brains of people living with Alzheimer's disease," Armstrong said in an email to CTVNews.ca Friday.

"If this treatment passes this Phase 1 trial, which examines the safety and tolerability in just 16 individuals with early-stage Alzheimer's disease, we will be following the future trials of Protollin to see if they result in the reduction of amyloid plaques and the slowing or reversal of cognitive decline in a larger group of patients."

CTVNews.ca Top Stories

A team of tornado experts is heading to Fergus, Ont. after a storm ripped through the area Sunday night.

Why brain aging can vary dramatically between people

Researchers are uncovering deeper insights into how the human brain ages and what factors may be tied to healthier cognitive aging, including exercising, avoiding tobacco, speaking a second language or even playing a musical instrument.

Local Spotlight

For the second year in a row, the ‘Gift-a-Family’ campaign is hoping to make the holidays happier for children and families in need throughout Barrie.

Some of the most prolific photographers behind CTV Skywatch Pics of the Day use the medium for fun, therapy, and connection.

A young family from Codroy Valley, N.L., is happy to be on land and resting with their newborn daughter, Miley, after an overwhelming, yet exciting experience at sea.

As Connor Nijsse prepared to remove some old drywall during his garage renovation, he feared the worst.

A group of women in Chester, N.S., has been busy on the weekends making quilts – not for themselves, but for those in need.

A Vancouver artist whose streetside singing led to a chance encounter with one of the world's biggest musicians is encouraging aspiring performers to try their hand at busking.

Ten-thousand hand-knit poppies were taken from the Sanctuary Arts Centre and displayed on the fence surrounding the Dartmouth Cenotaph on Monday.

A Vancouver man is saying goodbye to his nine-to-five and embarking on a road trip from the Canadian Arctic to Antarctica.